鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 4,430 | 4,430 | 4,295 | 4,355 | -100 | -2.2% | 92,100 |
| 2025/04/03 | 4,210 | 4,460 | 4,210 | 4,455 | -50 | -1.1% | 181,900 |
| 2025/04/02 | 4,595 | 4,615 | 4,480 | 4,505 | -65 | -1.4% | 77,100 |
| 2025/04/01 | 4,600 | 4,620 | 4,545 | 4,570 | -20 | -0.4% | 81,300 |
| 2025/03/31 | 4,600 | 4,625 | 4,560 | 4,590 | -105 | -2.2% | 76,600 |
| 2025/03/28 | 4,730 | 4,755 | 4,650 | 4,695 | -35 | -0.7% | 62,700 |
| 2025/03/27 | 4,660 | 4,730 | 4,660 | 4,730 | +10 | +0.2% | 60,100 |
| 2025/03/26 | 4,695 | 4,750 | 4,640 | 4,720 | +30 | +0.6% | 68,600 |
| 2025/03/25 | 4,740 | 4,740 | 4,595 | 4,690 | -70 | -1.5% | 88,000 |
| 2025/03/24 | 4,765 | 4,810 | 4,745 | 4,760 | +30 | +0.6% | 113,900 |
| 2025/03/21 | 4,680 | 4,780 | 4,640 | 4,730 | +50 | +1.1% | 102,800 |
| 2025/03/19 | 4,580 | 4,725 | 4,570 | 4,680 | +100 | +2.2% | 78,000 |
| 2025/03/18 | 4,565 | 4,600 | 4,530 | 4,580 | +10 | +0.2% | 65,800 |
| 2025/03/17 | 4,500 | 4,570 | 4,495 | 4,570 | +35 | +0.8% | 68,100 |
| 2025/03/14 | 4,580 | 4,580 | 4,455 | 4,535 | +10 | +0.2% | 73,500 |
| 2025/03/13 | 4,495 | 4,570 | 4,440 | 4,525 | +30 | +0.7% | 81,300 |
| 2025/03/12 | 4,355 | 4,555 | 4,355 | 4,495 | +100 | +2.3% | 96,300 |
| 2025/03/11 | 4,345 | 4,395 | 4,210 | 4,395 | ±0 | ±0% | 96,200 |
| 2025/03/10 | 4,450 | 4,480 | 4,355 | 4,395 | -55 | -1.2% | 90,900 |
| 2025/03/07 | 4,490 | 4,510 | 4,415 | 4,450 | -45 | -1% | 85,500 |
| 2025/03/06 | 4,495 | 4,510 | 4,440 | 4,495 | -5 | -0.1% | 114,400 |
| 2025/03/05 | 4,465 | 4,540 | 4,430 | 4,500 | +35 | +0.8% | 83,700 |
| 2025/03/04 | 4,400 | 4,485 | 4,355 | 4,465 | +90 | +2.1% | 164,200 |
| 2025/03/03 | 4,235 | 4,420 | 4,210 | 4,375 | +200 | +4.8% | 142,300 |
| 2025/02/28 | 4,250 | 4,300 | 4,170 | 4,175 | -95 | -2.2% | 101,700 |
| 2025/02/27 | 4,365 | 4,400 | 4,250 | 4,270 | -45 | -1% | 54,500 |
| 2025/02/26 | 4,245 | 4,360 | 4,245 | 4,315 | +100 | +2.4% | 117,300 |
| 2025/02/25 | 4,195 | 4,290 | 4,080 | 4,215 | +5 | +0.1% | 101,600 |
| 2025/02/21 | 4,245 | 4,300 | 4,180 | 4,210 | +35 | +0.8% | 147,100 |
| 2025/02/20 | 4,215 | 4,220 | 4,160 | 4,175 | -70 | -1.6% | 101,400 |
| 2025/02/19 | 4,320 | 4,350 | 4,245 | 4,245 | -85 | -2% | 74,300 |
| 2025/02/18 | 4,200 | 4,340 | 4,160 | 4,330 | +110 | +2.6% | 136,600 |
| 2025/02/17 | 4,445 | 4,485 | 4,165 | 4,220 | -240 | -5.4% | 260,100 |
| 2025/02/14 | 4,305 | 4,485 | 4,275 | 4,460 | +180 | +4.2% | 311,800 |
| 2025/02/13 | 4,200 | 4,300 | 4,190 | 4,280 | +130 | +3.1% | 251,600 |
| 2025/02/12 | 4,175 | 4,230 | 4,075 | 4,150 | -25 | -0.6% | 323,900 |
| 2025/02/10 | 4,530 | 4,700 | 4,125 | 4,175 | -855 | -17% | 809,000 |
| 2025/02/07 | 5,020 | 5,040 | 4,930 | 5,030 | +40 | +0.8% | 174,300 |
| 2025/02/06 | 4,890 | 5,000 | 4,875 | 4,990 | +115 | +2.4% | 99,100 |
| 2025/02/05 | 4,850 | 4,880 | 4,825 | 4,875 | -10 | -0.2% | 68,500 |
| 2025/02/04 | 4,910 | 4,970 | 4,860 | 4,885 | +5 | +0.1% | 116,000 |
| 2025/02/03 | 4,970 | 4,970 | 4,850 | 4,880 | -100 | -2% | 133,500 |
| 2025/01/31 | 5,000 | 5,010 | 4,930 | 4,980 | -20 | -0.4% | 74,700 |
| 2025/01/30 | 5,030 | 5,040 | 4,965 | 5,000 | -10 | -0.2% | 95,200 |
| 2025/01/29 | 5,030 | 5,050 | 4,990 | 5,010 | -20 | -0.4% | 103,700 |
| 2025/01/28 | 5,100 | 5,130 | 5,000 | 5,030 | -20 | -0.4% | 90,100 |
| 2025/01/27 | 5,040 | 5,070 | 5,000 | 5,050 | -20 | -0.4% | 91,600 |
| 2025/01/24 | 4,940 | 5,110 | 4,930 | 5,070 | +130 | +2.6% | 167,800 |
| 2025/01/23 | 4,860 | 5,050 | 4,850 | 4,940 | +75 | +1.5% | 261,700 |
| 2025/01/22 | 4,750 | 4,910 | 4,740 | 4,865 | +185 | +4% | 149,400 |
1～
50
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
